Skip to main content
Caplight Logo









Orient Speech Therapy

Orient Speech Therapy

Private
ShenzhenHealthcare & Life Scienceshttps://ostcn.com/

Last Round

Series D

Mar 7, 2022

Est. Valuation

$395M

Total Funding Raised

$138M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Orient Speech Therapy is a healthcare services company that provides speech and language therapy, clinical diagnosis, and therapeutic interventions for children with autism or speech disorders.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Patient Engagement, Telemedicine

Business Model

B2C

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Non-AI

Keywords

speech therapyautism interventionpediatric rehabilitationspeech pathologybehavioral therapyspecial educationonline-to-offlineO2Ospeech developmentearly screeningtherapist trainingchild developmentspeech delayautism support

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Orient Speech Therapy Comparables

Compare Orient Speech Therapy with similar companies based on industry and business-model similarity.

Orient Speech Therapy comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shenzhen Rice and Xiaomi Culture Communication
88%
Beijing Wucailu Children Development Center
83%
Beijing Peking University Medical Brain Health Technology Co., Ltd.
80%

Orient Speech Therapy Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DMar 7, 2022
Series C ExtensionJun 25, 2021
Series CFeb 5, 2021
Series BDec 18, 2017
Series AJan 1, 2015

Orient Speech Therapy Investors

Notable investors and investment history

Orient Speech Therapy investors
InvestorRounds
TemasekSeries C Extension
Northern Light Venture CapitalSeries C, Series B
F-Prime CapitalSeries B, Series A
Beijing Taikang Investment Management Co., Ltd.Series C Extension
Long Hill CapitalSeries B, Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 365% MoM, reaching 2K.

  • Mar 2, 2026

    Monthly visitors increased 307% MoM.

Orient Speech Therapy Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Orient Speech Therapy Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Orient Speech Therapy's valuation, stock price, and market status.

Firmographic Details

HeadquartersShenzhen
Employee Range171
Year Founded2007
Last FundingMar 7, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?